ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
The enduring importance of family health history in the era of genomic medicine and risk assessment.
Abstract
Improving disease risk prediction and tailoring preventive interventions to patient
risk factors is one of the primary goals of precision medicine. Family health history
is the traditional approach to quickly gather genetic and environmental data relevant
to the patient. While the utility of family health history is well-documented, its
utilization is variable, in part due to lack of patient and provider knowledge and
incomplete or inaccurate data. With the advances and reduced costs of sequencing technologies,
comprehensive sequencing tests can be performed as a risk assessment tool. We provide
an overview of each of these risk assessment approaches, the benefits and limitations
and implementation challenges.
Type
Journal articleSubject
family health historypatient education
provider education
risk assessment
sequencing
utility
utilization
Permalink
https://hdl.handle.net/10161/20584Published Version (Please cite this version)
10.2217/pme-2019-0091Publication Info
Haga, Susanne B; & Orlando, Lori A (2020). The enduring importance of family health history in the era of genomic medicine and
risk assessment. Per Med. 10.2217/pme-2019-0091. Retrieved from https://hdl.handle.net/10161/20584.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Susanne B Haga
Professor in Medicine
My research interests focus on issues affecting the translation of genomics to clinical
practice. Specifically, I have a strong interest in education, with each of my research
projects involving some component of professional, public or patient education, including
development of educational materials about genomic research in general, pharmacogenetic
testing, and communicating genetic test results, in addition to undergraduate teaching
in genetics/genomics, ethics, and policy.A
Lori Ann Orlando
Professor of Medicine
Dr. Lori A. Orlando, MD MHS MMCI is a Professor of Medicine and Director of the Precision
Medicine Program in the Center for Applied Genomics and Precision Medicine at Duke
University. She attended Tulane Medical Center for both medical school (1994-1998)
and Internal Medicine residency (1998-2000). There she finished AOA and received a
number of awards for teaching and clinical care from the medical school and the residency
programs, including the Musser-Burch-Puschett award in 2000 for acad
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info